VEGFA and nonpapillary renal cell carcinoma: Since VHL mutations occurred in 60–70% ccRCC cases and hypoxia-inducible factor (HIF) activated by VHL mutations could induce VEGFA expression for RCC angiogenesis3,16, we explored the association between RASAL2 and VHL status.